Biomarker Testing and Treatment Approach in NSCLC
Prevalence of EGFR Mutation Testing in Early Stage Lung Cancer: Implications of the ADAURA Trial for Clinical Practice
By
City of Hope
FEATURING
Erminia Massarelli
By
City of Hope
FEATURING
Erminia Massarelli
Login to view comments.
Click here to Login
Biomarker Testing and Treatment Approach in NSCLC